| # | Title | Journal | Year | Citations |
|---|
| 1 | RET/PTC Rearrangement in Thyroid Tumors | Endocrine Pathology | 2002 | 411 |
| 2 | Overview of the 2022 WHO Classification of Thyroid Neoplasms | Endocrine Pathology | 2022 | 388 |
| 3 | Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours | Endocrine Pathology | 2017 | 326 |
| 4 | Overview of the 2017 WHO Classification of Pituitary Tumors | Endocrine Pathology | 2017 | 319 |
| 5 | Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms | Endocrine Pathology | 2022 | 227 |
| 6 | Genetic Alterations Involved in the Transition from Well-Differentiated to Poorly Differentiated and Anaplastic Thyroid Carcinomas | Endocrine Pathology | 2004 | 204 |
| 7 | Differential Expression of miRNAs in Papillary Thyroid Carcinoma Compared to Multinodular Goiter Using Formalin Fixed Paraffin Embedded Tissues | Endocrine Pathology | 2007 | 196 |
| 8 | Changing Patterns in the Incidence and Survival of Thyroid Cancer with Follicular Phenotype—Papillary, Follicular, and Anaplastic: A Morphological and Epidemiological Study | Endocrine Pathology | 2007 | 183 |
| 9 | Overview of the 2022 WHO Classification of Pituitary Tumors | Endocrine Pathology | 2022 | 174 |
| 10 | Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms | Endocrine Pathology | 2016 | 168 |
| 11 | The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas | Endocrine Pathology | 2015 | 167 |
| 12 | Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form | Endocrine Pathology | 2008 | 150 |
| 13 | The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction | Endocrine Pathology | 2014 | 141 |
| 14 | Histological Grading of Adrenal and Extra-adrenal Pheochromocytomas and Relationship to Prognosis: A Clinicopathological Analysis of 116 Adrenal Pheochromocytomas and 30 Extra-adrenal Sympathetic Paragangliomas Including 38 Malignant Tumors | Endocrine Pathology | 2005 | 140 |
| 15 | Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma | Endocrine Pathology | 2016 | 140 |
| 16 | Papillary Carcinoma of Thyroid: A 30-yr Clinicopathological Review of the Histological Variants | Endocrine Pathology | 2005 | 139 |
| 17 | Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas | Endocrine Pathology | 1999 | 124 |
| 18 | Radiation-induced thyroid cancer: What we have learned from Chernobyl | Endocrine Pathology | 2006 | 122 |
| 19 | Distinction Between Papillary Thyroid Hyperplasia and Papillary Thyroid Carcinoma by Immunohistochemical Staining for Cytokeratin 19, Galectin-3, and HBME-1 | Endocrine Pathology | 2003 | 117 |
| 20 | Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas | Endocrine Pathology | 2022 | 115 |
| 21 | Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies | Endocrine Pathology | 2014 | 113 |
| 22 | MicroRNA Expression Profiles in Thyroid Tumors | Endocrine Pathology | 2009 | 110 |
| 23 | Alterations of the BRAF Gene in Thyroid Tumors | Endocrine Pathology | 2005 | 101 |
| 24 | Prognostic Factors in Gastrointestinal Endocrine Tumors | Endocrine Pathology | 2007 | 100 |
| 25 | Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study | Endocrine Pathology | 1995 | 99 |
| 26 | Overview of the 2022 WHO Classification of Parathyroid Tumors | Endocrine Pathology | 2022 | 96 |
| 27 | Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification | Endocrine Pathology | 2012 | 95 |
| 28 | Diagnostic Value of Differential Expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in Benign and Malignant Follicular-Derived Lesions of the Thyroid: An Immunohistochemical Tissue Microarray Analysis | Endocrine Pathology | 2006 | 93 |
| 29 | Molecular Analysis of Thyroid Tumors | Endocrine Pathology | 2011 | 93 |
| 30 | Spectrum of Different Types of Hypophysitis: A Clinicopathologic Study of Hypophysitis in 31 Cases | Endocrine Pathology | 2002 | 92 |
| 31 | Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms | Endocrine Pathology | 2018 | 89 |
| 32 | Cdx2 as a Marker for Neuroendocrine Tumors of Unknown Primary Sites | Endocrine Pathology | 2004 | 88 |
| 33 | P53 Gene Mutations in Pituitary Carcinomas | Endocrine Pathology | 2007 | 88 |
| 34 | Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining | Endocrine Pathology | 2008 | 88 |
| 35 | Overview of the 2022 WHO Classification of Adrenal Cortical Tumors | Endocrine Pathology | 2022 | 87 |
| 36 | Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice: Perspectives for Surgical Pathology and Cytopathology | Endocrine Pathology | 2018 | 86 |
| 37 | The Chromogranins: Their Roles in Secretion from Neuroendocrine Cells and as Markers for Neuroendocrine Neoplasia | Endocrine Pathology | 2003 | 84 |
| 38 | Well-Differentiated Thyroid Carcinoma with Concomitant Hashimoto’s Thyroiditis Present with Less Aggressive Clinical Stage and Low Recurrence | Endocrine Pathology | 2011 | 83 |
| 39 | Prevalence of Papillary Microcarcinoma of the Thyroid in Brazilian Autopsy and Surgical Series | Endocrine Pathology | 2006 | 82 |
| 40 | BRAF V600E Mutation in Papillary Thyroid Carcinoma: Significant Association with Node Metastases and Extra Thyroidal Invasion | Endocrine Pathology | 2012 | 82 |
| 41 | Understanding the Genetic Basis of Parathyroid Carcinoma | Endocrine Pathology | 2014 | 82 |
| 42 | Use and Abuse of Frozen Section in the Diagnosis of Follicular Thyroid Lesions | Endocrine Pathology | 2005 | 81 |
| 43 | The Many Faces and Mimics of Papillary Thyroid Carcinoma | Endocrine Pathology | 2006 | 78 |
| 44 | Immunohistochemistry in Diagnostic Parathyroid Pathology | Endocrine Pathology | 2018 | 78 |
| 45 | Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas | Endocrine Pathology | 1995 | 77 |
| 46 | C-Cell Hyperplasia and Medullary Thyroid Microcarcinoma | Endocrine Pathology | 2001 | 76 |
| 47 | Challenging Lesions in the Differential Diagnosis of Endocrine Tumors: Parathryoid Carcinoma | Endocrine Pathology | 2008 | 76 |
| 48 | Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland | Endocrine Pathology | 1991 | 75 |
| 49 | Thyroid Cancer, Thyroiditis and Dietary Iodine: A Review Based on the Salta, Argentina Model | Endocrine Pathology | 2008 | 75 |
| 50 | Familial Non-Medullary Thyroid Carcinoma: An Update | Endocrine Pathology | 2008 | 75 |
